Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01751633
Other study ID # Spine FA3
Secondary ID
Status Terminated
Phase
First received
Last updated
Start date January 2013
Est. completion date December 2015

Study information

Verified date August 2020
Source AO Innovation Translation Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Thoracolumbar fractures are the most common spinal fractures with an average annual incidence between 18 and 30 per 100'000 inhabitants. The majority of these fractures are AO type A3 ("burst fractures"). Although patients with burst fractures report a reduced quality of life and chronic pain, there is no clear evidence whether surgical or conservative treatment offer better functional and back-pain related outcomes. The indications for the selection of an ideal treatment for these fractures without neurological deficits remain controversial. The purpose of this study is to evaluate whether patients with thoracolumbar fractures without neurological deficit being surgically treated show faster recovery and better improvement of function than patients being conservatively treated.


Recruitment information / eligibility

Status Terminated
Enrollment 38
Est. completion date December 2015
Est. primary completion date March 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Age 18-65 years

- Diagnosis of single or multiple stable thoracolumbar fracture(s)

- Level T10- L3

- Type AO A3 or A4

- Radiologically confirmed by Rx or CT

- Fracture induced kyphotic deformity lower or equal to 20-35 degrees

- Definitive treatment (surgical or conservative) within 10 days after injury

- American Spinal Injury Association (ASIA) Impairment Scale = E (normal )

- Ability to understand patient information / informed consent form

- Willingness and ability to participate in the clinical investigation including imaging and follow-up procedures (FUs)

- Signed informed consent

Exclusion Criteria:

- Open fracture

- Polytrauma

- Pathologic fracture

- Disruption of the posterior ligamentous complex between T10 and L3

- Clinically evident osteoporosis as assessed by the investigator

- Spinal luxation

- Associated severe lesions as assessed by the investigator

- Spinal lesion due to gun or projectile

- Pre-existing spinal column deformity

- Prior spinal surgeries

- BMI > 40 kg/m2

- Any severe medically not managed systemic disease

- Recent history of substance abuse (ie, recreational drugs, alcohol) that would preclude reli-able assessment

- Pregnancy or women planning to conceive within the study period

- Prisoner

- Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study

Study Design


Related Conditions & MeSH terms

  • Fractures, Bone
  • Multiple Level Stable Thoracolumbar Fracture Type AO A3
  • Single Level Stable Thoracolumbar Fracture Type AO A3

Intervention

Procedure:
Surgical

Conservative treatment


Locations

Country Name City State
Brazil Hospital Universitaria Cajuru Curitiba
Brazil Hospital Cristo Redentor Porto Alegre
Brazil Hospital Santa Marcelina São Paulo
Chile Hospital Cristo Redentor Santiago de Chile
Czechia Krajská nemocnice Liberec Liberec
Germany Klinikum rechts der Isar der Technischen Universität München Munich
Italy Azienda Ospedaliero - Universitaria Policlinico Catania
Portugal Hospital Garcia e Orta, EPE Almada

Sponsors (1)

Lead Sponsor Collaborator
AO Clinical Investigation and Publishing Documentation

Countries where clinical trial is conducted

Brazil,  Chile,  Czechia,  Germany,  Italy,  Portugal, 

Outcome

Type Measure Description Time frame Safety issue
Primary Roland-Morris Disability Questionnaire (RMDQ) Improvement in functional outcome from baseline to 6 week follow up (FU) measured with the Roland-Morris Disability Questionnaire (RMDQ) 6 week follow up
Secondary Back pain related disability (Roland-Morris Disability Questionnaire RMDQ) Assessed at baseline, 6 weeks, 3, 6, 12 and 24 months follow up
Secondary Pain (Numeric Rating Scale (NRS)) Assessed at baseline, 6 weeks, 3, 6, 12 and 24 months FU
Secondary Radiologic progress taking into account RX, CT and optionally MRI baseline and at follow up after 6 weeks, 3, 6, 12 and 24 months
Secondary Quality of return to work (Denis Work Scale) Assessed at baseline, 6 weeks, 3, 6, 12 and 24 months follow up
Secondary Time to return to work Assessed at baseline, 6 weeks, 3, 6, 12 and 24 months follow up
Secondary Conservative treatment failure rate (eg, change to surgical treatment) Assessed at baseline, 6 weeks, 3, 6, 12 and 24 months follow up
Secondary Rates of local adverse events (AE) Assessed at baseline, 6 weeks, 3, 6, 12 and 24 months follow up